PE20151084A1 - Derivados de pirimidinona inhibidoras de la elastasa de neutrofilos humanos (hne) - Google Patents
Derivados de pirimidinona inhibidoras de la elastasa de neutrofilos humanos (hne)Info
- Publication number
- PE20151084A1 PE20151084A1 PE2015000931A PE2015000931A PE20151084A1 PE 20151084 A1 PE20151084 A1 PE 20151084A1 PE 2015000931 A PE2015000931 A PE 2015000931A PE 2015000931 A PE2015000931 A PE 2015000931A PE 20151084 A1 PE20151084 A1 PE 20151084A1
- Authority
- PE
- Peru
- Prior art keywords
- hne
- alkyl
- inhibiting human
- pyrimidinone derivatives
- derivatives inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/19—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/02—Formic acid
- C07C53/06—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se refiere a derivados de 3-oxo-7-metil-8-(3-trifluorometil-fenil)-[1, 2, 4]triazolo[4, 3-a]pirimidina de formula (I), donde A, B y D son independientemente CH o N; R1 es H, (C1-C6)alquilo, fenil(C1-C6)alquilo, -CH2(CH2)OH, -CH2CONH2, -CH2SO2NH2, entre otros; R2 es -CONH2, C2-C6-alquenilo opcionalmente sustituido con OH o NH2, entre otros; y R3 es CN o -C(O)-XR4, donde X es -O-, -CH2- o -NH-; y R4 es H, (C1-C6)alquilo, entre otros. Los compuestos de la invencion son inhibidores de la elastasa de neutrofilos humanos (HNE), por lo cual son utiles en el tratamiento de enfermedades mediadas por la accion de la HNE, tales como enfermedad pulmonar obstructiva cronica (EPOC), fibrosis quistica, bronquiectasias, entre otros
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197767 | 2012-12-18 | ||
| EP13158757 | 2013-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20151084A1 true PE20151084A1 (es) | 2015-08-07 |
Family
ID=50030225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015000931A PE20151084A1 (es) | 2012-12-18 | 2013-12-16 | Derivados de pirimidinona inhibidoras de la elastasa de neutrofilos humanos (hne) |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US9365577B2 (es) |
| EP (1) | EP2935274B1 (es) |
| JP (1) | JP6390919B2 (es) |
| KR (1) | KR102197721B1 (es) |
| CN (1) | CN104870449B (es) |
| AU (1) | AU2013363783B2 (es) |
| BR (1) | BR112015014438B1 (es) |
| CA (1) | CA2895352C (es) |
| CL (1) | CL2015001678A1 (es) |
| CY (1) | CY1122368T1 (es) |
| DK (1) | DK2935274T3 (es) |
| EA (1) | EA028507B1 (es) |
| ES (1) | ES2700226T3 (es) |
| GE (1) | GEP20186885B (es) |
| HK (1) | HK1212985A1 (es) |
| HR (1) | HRP20182007T1 (es) |
| IL (1) | IL239447B (es) |
| LT (1) | LT2935274T (es) |
| MX (1) | MX2015007379A (es) |
| NZ (1) | NZ709153A (es) |
| PE (1) | PE20151084A1 (es) |
| PH (1) | PH12015501043B1 (es) |
| PL (1) | PL2935274T3 (es) |
| PT (1) | PT2935274T (es) |
| RS (1) | RS58129B1 (es) |
| SA (1) | SA515360612B1 (es) |
| SG (2) | SG10201703484YA (es) |
| SI (1) | SI2935274T1 (es) |
| TN (1) | TN2015000276A1 (es) |
| TW (1) | TWI675837B (es) |
| UA (1) | UA118021C2 (es) |
| WO (1) | WO2014095700A1 (es) |
| ZA (1) | ZA201504331B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有ｍａｂａ化合物和皮質類固醇之組合 |
| CA2933725A1 (en) * | 2013-12-16 | 2015-06-25 | Chiesi Farmaceutici S.P.A. | Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors |
| US9487528B2 (en) | 2014-06-09 | 2016-11-08 | Chiesi Farmaceutici S.P.A. | Compounds |
| WO2015188866A1 (en) * | 2014-06-12 | 2015-12-17 | Chiesi Farmaceutici S.P.A. | Novel compounds |
| US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| US9657015B2 (en) | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
| TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物 |
| US9890169B2 (en) | 2015-12-14 | 2018-02-13 | Chiesi Farmaceutici S.P.A. | Triazolinone compounds as HNE inhibitors |
| AR108609A1 (es) | 2016-05-31 | 2018-09-05 | Chiesi Farm Spa | Derivados de imidazolona y pirazolona como inhibidores de la elastasa de neutrófilos humana (hne) |
| SG10201912143UA (en) | 2016-05-31 | 2020-02-27 | Chiesi Farm Spa | Imidazolone compounds as human neutrophil elastase inhibitors |
| EP3464268B1 (en) | 2016-05-31 | 2020-03-11 | Chiesi Farmaceutici S.p.A. | Novel compounds |
| CN112969490B (zh) | 2018-10-30 | 2024-07-12 | 奇斯药制品公司 | 用于向机械辅助呼吸患者施用药物的设备 |
| EP4034079A1 (en) | 2019-09-24 | 2022-08-03 | Chiesi Farmaceutici S.p.A. | Novel carrier particles for dry powder formulations for inhalation |
| KR20240124375A (ko) | 2021-12-22 | 2024-08-16 | 키에시 파르마슈티시 엣스. 피. 에이. | 호중구 엘라스타제 억제제로서 트라이아졸론 유도체 염 |
| AU2022418176A1 (en) | 2021-12-22 | 2024-08-01 | Chiesi Farmaceutici S.P.A. | Triazolone derivative salt as neutrophil elastase inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| SK132498A3 (en) * | 1996-03-28 | 1999-08-06 | Glaxo Group Ltd | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| GB0608844D0 (en) * | 2006-05-04 | 2006-06-14 | Argenta Discovery Ltd | Enzyme inhibitors |
| DE102009004197A1 (de) * | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung |
| GB201004179D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| GB201004178D0 (en) | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
| WO2013037809A1 (en) * | 2011-09-14 | 2013-03-21 | Chiesi Farmaceutici S.P.A. | Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors |
-
2013
- 2013-12-16 KR KR1020157016352A patent/KR102197721B1/ko active IP Right Grant
- 2013-12-16 NZ NZ709153A patent/NZ709153A/en unknown
- 2013-12-16 SG SG10201703484YA patent/SG10201703484YA/en unknown
- 2013-12-16 LT LTEP13826565.7T patent/LT2935274T/lt unknown
- 2013-12-16 PE PE2015000931A patent/PE20151084A1/es unknown
- 2013-12-16 ES ES13826565T patent/ES2700226T3/es active Active
- 2013-12-16 JP JP2015547060A patent/JP6390919B2/ja active Active
- 2013-12-16 PL PL13826565T patent/PL2935274T3/pl unknown
- 2013-12-16 EA EA201590962A patent/EA028507B1/ru unknown
- 2013-12-16 TW TW102146370A patent/TWI675837B/zh active
- 2013-12-16 UA UAA201505958A patent/UA118021C2/uk unknown
- 2013-12-16 SG SG11201504737RA patent/SG11201504737RA/en unknown
- 2013-12-16 GE GEAP201313860A patent/GEP20186885B/en unknown
- 2013-12-16 PT PT13826565T patent/PT2935274T/pt unknown
- 2013-12-16 WO PCT/EP2013/076672 patent/WO2014095700A1/en active Application Filing
- 2013-12-16 MX MX2015007379A patent/MX2015007379A/es active IP Right Grant
- 2013-12-16 RS RS20181517A patent/RS58129B1/sr unknown
- 2013-12-16 DK DK13826565.7T patent/DK2935274T3/en active
- 2013-12-16 SI SI201331244T patent/SI2935274T1/sl unknown
- 2013-12-16 AU AU2013363783A patent/AU2013363783B2/en active Active
- 2013-12-16 BR BR112015014438-1A patent/BR112015014438B1/pt active IP Right Grant
- 2013-12-16 EP EP13826565.7A patent/EP2935274B1/en active Active
- 2013-12-16 CA CA2895352A patent/CA2895352C/en active Active
- 2013-12-16 CN CN201380065981.1A patent/CN104870449B/zh active Active
- 2013-12-17 US US14/108,904 patent/US9365577B2/en active Active
-
2015
- 2015-05-11 PH PH12015501043A patent/PH12015501043B1/en unknown
- 2015-06-15 ZA ZA2015/04331A patent/ZA201504331B/en unknown
- 2015-06-16 CL CL2015001678A patent/CL2015001678A1/es unknown
- 2015-06-16 TN TNP2015000276A patent/TN2015000276A1/fr unknown
- 2015-06-16 IL IL239447A patent/IL239447B/en active IP Right Grant
- 2015-06-17 SA SA515360612A patent/SA515360612B1/ar unknown
-
2016
- 2016-01-29 HK HK16101053.4A patent/HK1212985A1/zh unknown
- 2016-05-10 US US15/150,749 patent/US9828382B2/en active Active
-
2018
- 2018-11-07 CY CY20181101168T patent/CY1122368T1/el unknown
- 2018-11-29 HR HRP20182007TT patent/HRP20182007T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20151084A1 (es) | Derivados de pirimidinona inhibidoras de la elastasa de neutrofilos humanos (hne) | |
| CR20130339A (es) | Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos | |
| CL2012000981A1 (es) | Compuestos derivados de 5-etinil-2-[(3-fenil-1h-pirazolo[3.4-d]pirimidin-1-il)metil]quinazolin-4(3h)-ona, inhibidores de fosfoinositida 3-quinasa compuestos intermediarios; sin accion farmacologica; composicion farmaceutica; utiles en el tratamiento de epoc, asma fibrosis quistica y pulmonar, sarcoidosis, entre otras. | |
| EA201070988A1 (ru) | Противовирусные терапевтические средства | |
| HN2011001256A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratmiento o prevencion de diabetes | |
| ATE517107T1 (de) | Pyrrolopyrazinkinaseinhibitoren | |
| CR10682A (es) | Compuestos de tiazol pirazolopirimidina | |
| CY1117773T1 (el) | Νεες χειρικες ν-ακυλ-5,6,7,8-υποκατεστημενες)-τετραϋδρο-[1,2,4]τριαζολο[4,3-a]πυραζινες ως επιλεκτικοι ανταγωνιστες του υποδοχεα νκ-3, φαρμακευτικη συνθεση και μεθοδοι για τη χρηση σε διαταραχες μεσολαβουμενες απο τον υποδοχεα νκ-3 | |
| PE20121617A1 (es) | Derivados de oxazina como inhibidores de bace | |
| PE20130779A1 (es) | Pirimidinas y triazinas condensadas y su uso | |
| PE20120505A1 (es) | Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a | |
| PE20091734A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| ATE522536T1 (de) | Pyrrolopyrazin-kinasehemmer | |
| CR20110620A (es) | Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus | |
| CR10343A (es) | Aminotetrahidropiranos como inihibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes | |
| EA201492204A1 (ru) | Нуклеозиды на основе урацила и спирооксетана | |
| CL2009000405A1 (es) | Compuestos derivados de pirrolo [2,3 b] pirazina, inhibidores jak y cyk; y sus usos en el tratamiento de enfermedades inflamatorias, autoinmune y cancer. | |
| CR11130A (es) | Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados | |
| ECSP088184A (es) | Derivados de benzoquinazolina y su uso en el tratamiento de enfermedades óseas | |
| PE20121180A1 (es) | (heteroarilmetil) tiohidantoinas sustituidas como drogas anticancer | |
| CR9947A (es) | Compuestos de pirimidinil benzotiofeno | |
| PE20080931A1 (es) | Imidazopirazinas como inhibidores de proteina quinasa | |
| PE20120494A1 (es) | {5-[4-(3,3-DIMETIL-AZETIDINA-1-CARBONIL)-FENIL]-[1,2,4]TRIAZOLO[1,5-a]PIRIDIN-2-IL}-AMIDA DE ACIDO CICLOPROPANOCARBOXILICO COMO INHIBIDOR DE LAS QUINASAS JANUS | |
| UY35182A (es) | ?COMPUESTOS DE HEXAHIDROPIRANO[ 3,4-d][1,3]TIAZIN-2-AMINA? . | |
| CU24103B1 (es) | Compuestos derivados amido espirocíclicos y sales farmacéuticamente aceptable de los mismos |